Stocks and Investing Stocks and Investing
Fri, August 5, 2022

Swayampakula Ramakanth Maintained (BCYC) at Strong Buy with Decreased Target to $57 on, Aug 5th, 2022


Published on 2024-10-27 22:29:03 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Decreased Target from $65 to $57 on, Aug 5th, 2022.

Swayampakula has made no other calls on BCYC in the last 4 months.



There are 5 other peers that have a rating on BCYC. Out of the 5 peers that are also analyzing BCYC, 1 agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $33 on, Wednesday, April 13th, 2022


These are the ratings of the 4 analyists that currently disagree with Swayampakula


  • Peter Lawson of "Barclays" Initiated at Buy and Held Target at $30 on, Thursday, July 28th, 2022
  • William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $60 on, Wednesday, July 6th, 2022
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Monday, May 23rd, 2022
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, April 12th, 2022
Contributing Sources